03:27:54 EST Mon 26 Feb 2024
Enter Symbol
or Name

Login ID:
Infinity Stone Ventures Corp
Symbol GEMS
Shares Issued 64,819,421
Close 2022-08-12 C$ 0.225
Market Cap C$ 14,584,370
Recent Sedar Documents

Infinity Stone closes $400K first tranche of financing

2022-08-15 16:06 ET - News Release

Mr. Zayn Kalyan reports


Infinity Stone Ventures Corp. has closed the first tranche a non-brokered private placement of flow-through units of the company through the issuance of two million units at a price of 20 cents per unit, for gross proceeds of $400,000. Each Unit is comprised of one Class A Subordinate Voting Share (a "Share") and one-half (1/2) of one share purchase warrant (a "Warrant"). Each whole Warrant is exercisable into one (1) Share (a "Warrant Share") at a price of $0.30 for a period of three (3) years from the date of issuance.

In connection with the second tranche, the Company issued 140,000 finders' warrants, and paid finder's fees of $28,000. Each finders' warrant is exercisable at a price of $0.30 for a period of three (3) years from the date of issuance.

The gross proceeds from the Offering will be used to incur eligible "Canadian exploration expenses" ("CEE") that are "flow-through mining expenditures" (as such term is defined in the Income Tax Act (Canada)) related to the Company's mining projects.

About Infinity Stone Ventures

Infinity Stone's mission is to be a diversified, single source supplier for the critical energy metals being used in the clean energy revolution alongside its established SaaS solution portfolio. The Company's primary business units include HealthCheck (Stratum Health Technologies LLC) and its energy metals portfolio. Infinity Stone is meeting the demand from battery and wind turbine manufacturers, nuclear and hydrogen energy producers, and energy metals speculators by acquiring 100% interest in critical mineral deposits and occurrences in stable mining-friendly jurisdictions, close to final use destinations in North American manufacturing hubs.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.